Patents Represented by Attorney Farelli Haag & Kilger PLLC
  • Patent number: 8217016
    Abstract: The present invention relates to a pharmaceutical composition comprising at least one mRNA comprising at least one coding region for at least one antigen from a tumour, in combination with an aqueous solvent and preferably a cytokine, e.g. GM-CSF, and a process for the preparation of the pharmaceutical composition. The pharmaceutical composition according to the invention is used in particular for therapy and/or prophylaxis against cancer.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: July 10, 2012
    Assignee: CUREVAC GmbH
    Inventors: Ingmar Hoerr, Florian Von Der Mulbe, Steve Pascolo